Virtual Experiences Should Not Be Recreations of Physical Ones

Whether you’re an integrator, a designer or simply a label-defying creative, the experience is everything. Host Bryan Meszaros explores the story behind the exhibit to understand how a carefully crafted experience traps into the human experience to connect people to place.

 

The evolution of experience design is here. It certainly wasn’t a static element for brands, but the pandemic certainly disrupted it like never before. Talking about this evolution, or possible revolution, Experience by Design host Bryan Meszaros welcomed Christophe Castagnera, Head of Connected Experiences at Imagination. Imagination is an experience agency that offers consulting, design, and creative services for brands worldwide. Castagnera serves as a chief strategist and has over two decades of experience telling brand stories.

“The last year has challenged the way we create experiences. It was a lot of reimagining. There were opportunities to seize the moment, so I wrote a Playbook discussing technology, curated experiences, and building at-home experiences,” Castagnera explained.

In the last year, the industry had many lessons learned moments. “Investing in technology was a possibility, but not everyone had the funds. People were still touching their mobile phones, so that became an avenue,” he shared.

Trying to recreate an in-person experience online didn’t really work. Those companies that succeeded found new ways to do virtual rather than mimicking physical experiences. The test and try model was good for many brands. “Some were being bold, they learned things, and are being rewarded. Where others lost share of voice that were passive.”

Castagnera offered several examples of brands’ creative moments. “Rabbit Hole bourbon had staff become virtual hosts for consumers in their home, and they suddenly were having these conversations. Around 70% of people are up for a brand experience in their home.”

Castagnera also talked about VR opportunities discovered. “If you can build a proper brand world around it, it works. Otherwise, it’s just bad ‘reality.’ The ecosystem has to be rich.”

Join host Bryan Meszaros on Experience by Design every other Wednesday as he explores the latest trends and solutions helping craft the world’s most intriguing experiences.

 

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More